Clinical trial No longer in our active list Observational Ages 55 and up

Collecting patient feedback on low-dose radiation for osteoarthritis

Official title: Patient Reported Outcomes Following Low-dose Irradiation for Osteoarthritis (PRO-LO): A Single-arm Prospective Registry

Run by University of North Carolina, Chapel Hill · NCT05705947 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is trying to see how low-dose radiation therapy affects pain and quality of life for people with osteoarthritis by collecting their feedback after treatment.

Quick facts

Study typeObservational
Ages55 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity of North Carolina, Chapel Hill
Academic / other
Drugs / interventionsradiation
Locations1 site (Chapel Hill, North Carolina)
Trial IDNCT05705947 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 55 and older with osteoarthritis in at least one joint, experiencing inadequately controlled pain despite previous treatments.

Probably not a fit

Patients who are pregnant, have a life expectancy of less than six months, or have shoulder osteoarthritis will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather data on patient-reported outcomes such as pain, function, and quality of life in individuals with osteoarthritis receiving standard radiation therapy. It is a single-institution, single-arm study that will systematically collect information to optimize radiation therapy management and clinical care. The primary focus is on changes in pain levels measured by a visual analog scale three months after treatment, alongside secondary endpoints assessing disease control and potential surgery avoidance. Participants will complete surveys to report their experiences and outcomes.

Why it matters

Potential benefit: If successful, this study could enhance the management of osteoarthritis through improved understanding of radiation therapy's effects on pain and function.

How similar studies have gone: While there is limited data on the specific use of low-dose radiation for osteoarthritis, similar approaches in pain management have shown promise in other contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Willing and able to provide informed consent
* Established diagnosis of OA of at least 1 joint
* Inadequately controlled pain due to OA despite attempts with 2 or more other treatment modalities and Visual Analogue Pain Score of 4 or greater.
* Will undergo radiation as part of their standard of care for OA.
* At least 55 years old
* Ability to read and speak English.

Exclusion Criteria:

* Any woman who is pregnant or has reason to believe she is pregnant (the possibility of pregnancy has to be excluded by negative urine ß-HCG results, obtained within 2 weeks of CT simulation for radiation planning, or on the basis of patient history, e.g.: tubal ligation, hysterectomy or a minimum of 1 year without menses).
* Estimated life expectancy less than 6 months.
* Radiation treatment for shoulder OA
* Patient weight greater than 550lbs

Where it's running

  • UNC Chapel Hill
    Chapel Hill, North Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Theodore Yanagihara, MD, PhD — University of North Carolina, Chapel Hill
  • Study coordinator: Victoria Xu
  • Email: victoria_xu@med.unc.edu
  • Phone: 984-974-8744

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.